107 related articles for article (PubMed ID: 3327891)
21. [Sarcomatoid renal carcinoma].
Leucumberri Castaños D; Podilla Nieva J; Albisu Tristán A; Pertusa Peña CP
Arch Esp Urol; 1998 Oct; 51(8):772-5. PubMed ID: 9859582
[TBL] [Abstract][Full Text] [Related]
22. Primary carcinoid tumors of the kidney.
Romero FR; Rais-Bahrami S; Permpongkosol S; Fine SW; Kohanim S; Jarrett TW
J Urol; 2006 Dec; 176(6 Pt 1):2359-66. PubMed ID: 17085102
[TBL] [Abstract][Full Text] [Related]
23. [A clinical survey on malignant tumors of upper urinary tract in a 10-year period].
Oheda T; Hayata S; Takeda K; Asahi T; Ohkita K
Hinyokika Kiyo; 1987 Dec; 33(12):2001-9. PubMed ID: 3448925
[TBL] [Abstract][Full Text] [Related]
24. [Metastatic tumors of unknown origin: when can intervention be justified?].
Gervaz P; Givel JC
Helv Chir Acta; 1993 Sep; 60(1-2):43-6. PubMed ID: 7693619
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
26. [Kidney tumors: clinical and pathological findings and detection].
André M; Hélénon O; De Fromont M; Correas J; Petit P; Bartoli J; Coulange C
J Radiol; 2002 Jun; 83(6 Pt 2):773-83, discussion 84-5. PubMed ID: 12218850
[TBL] [Abstract][Full Text] [Related]
27. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
[TBL] [Abstract][Full Text] [Related]
28. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
Holmäng S; Lele SM; Johansson SL
J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
[TBL] [Abstract][Full Text] [Related]
29. Proposed staging system for gastrointestinal carcinoid tumors.
Landry CS; McMasters KM; Scoggins CR; Martin RC
Am Surg; 2008 May; 74(5):418-22. PubMed ID: 18481499
[TBL] [Abstract][Full Text] [Related]
30. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
[TBL] [Abstract][Full Text] [Related]
31. [Tumors of the upper urinary tract. Analysis of a series of 85 cases].
Loze JF; Ducassou J; Hermanowicz M; Serment G; Richaud C
J Urol (Paris); 1984; 90(2):111-6. PubMed ID: 6491344
[TBL] [Abstract][Full Text] [Related]
32. Parotid tumors: a 10-year experience.
Lin CC; Tsai MH; Huang CC; Hua CH; Tseng HC; Huang ST
Am J Otolaryngol; 2008; 29(2):94-100. PubMed ID: 18314019
[TBL] [Abstract][Full Text] [Related]
33. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
35. Malignant renal tumors in adults: a ten-year review in a Nigerian hospital.
Badmus TA; Salako AA; Arogundade FA; Sanusi AA; Adesunkanmi AR; Oyebamiji EO; Bakare TI; Oseni GO
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):120-6. PubMed ID: 18087141
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study on incidental renal cell carcinoma].
Yamaguchi K; Tominaga T; Nishimura Y
Hinyokika Kiyo; 1995 Feb; 41(2):93-9. PubMed ID: 7702013
[TBL] [Abstract][Full Text] [Related]
37. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
38. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
39. [Adenocarcinoma of the kidney (hypernephroma)].
Probst W; Joss R; Triller J; Schönenberger A; Greiner R; Brunner KW
Schweiz Med Wochenschr; 1984 Oct; 114(41):1406-15. PubMed ID: 6208605
[TBL] [Abstract][Full Text] [Related]
40. Cystic renal cell carcinoma: biology and clinical behavior.
Han KR; Janzen NK; McWhorter VC; Kim HL; Pantuck AJ; Zisman A; Figlin RA; Dorey FJ; Said JW; Belldegrun AS
Urol Oncol; 2004; 22(5):410-4. PubMed ID: 15464922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
